The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 18, 2007
Filed:
Sep. 21, 2001
Neal Rosen, Englewood, NJ (US);
Scott D. Kuduk, New York, NY (US);
Samuel J. Danishefsky, Englewood, NJ (US);
Furzhong F. Zheng, New York, NY (US);
Laura Sepp-lorenzino, New Haven, CT (US);
Ouatek Ouerfelli, New York, NY (US);
Neal Rosen, Englewood, NJ (US);
Scott D. Kuduk, New York, NY (US);
Samuel J. Danishefsky, Englewood, NJ (US);
Furzhong F. Zheng, New York, NY (US);
Laura Sepp-Lorenzino, New Haven, CT (US);
Ouatek Ouerfelli, New York, NY (US);
Sloan-Kettering Institute for Cancer Research, New York, NY (US);
Abstract
Bifunctional molecules comprising two hsp-binding moieties which bind to hspin the pocket to which ansamycin antibiotics bind connected via a linker are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases. For example, a compound of two geldanamycin moities joined by a four-carbon linker provides selective degradation of HER-family tyrosine kinases, without substantially affecting other kinases. These compounds can be used for treatment of HER-positive cancers with reduced toxicity, since these compounds potently kill cancer cells but affect fewer proteins than geldanamycin.